Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
13 May 2011

IN THIS ISSUE
Alkermes–Elan deal
Pay-to-delay
FDA guidance
PTE May

 
Alkermes snaps up Elan Drug Technologies
Alkermes has purchased Elan's Elan Drug Technologies (EDT) unit in a cash and stock transaction worth approximately $960 million, whereby the two companies will be merged into a new holding company in Ireland under the name Alkermes plc. More...
 
Pay-to-delay deals increase by 60%
The number of patent settlements in which the manufacturers of branded products paid makers of generic drugs to postpone the introduction of their products reached its highest level ever in fiscal year 2010, according to a Federal Trade Commission staff report. More...
 
FDA issues guidance on bioequivalence studies
The FDA has issued a new guidance for industry concerning the submission of summary bioequivalence data for abbreviated new drug applications, designed to clarify the requirements for the submission of bioequivalence data that were published in 2009. More...
 
Have you seen...?
The May issue of Pharmaceutical Technology Europe? This month's issue includes articles on UK pharma, emerging markets, capsule cross linking and a special feature on packaging. More...
 
PhRMA comments on pharmaceutical trade practices report
The Office of the United States Trade Representative has issued a report that addresses IPR protection and enforcement, and specific initiatives such as measures relating to anticounterfeiting and market access. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...
 

Latest blog posts
User fees: another step in the US pathway for biosimilars
Knowing when to stay the blade
Serono in $44-million False Claims allegations
More blog posts

Latest columns
Could the UK be losing its pharma lustre?
Supply chain pain
The marriage of small molecules and biologics
More articles

Upcoming events
Chemspec Europe 2011 (15–16 June | Switzerland)
10th Annual Biological Production Forum 2011 (20–22 June | Germany)
IVT's 2nd Annual ACE (21–23 June | USA)
More events

Product/Service Profiles
3M

For over 50 years, pharmaceutical companies have looked to 3M Drug Delivery Systems for ingenious inhalation and transdermal systems, components and manufacturing to help enable success.
Read more

 
Accugenix

FDA-registered and cGMP compliant, we are the world's foremost provider of leading-edge technologies for microbial identification and characterization services. We challenge you to find a contract lab or purchased system that provides both quality results and a greater return on your investment. A thorough evaluation process for microbial identification systems should consist of both a technical and financial review.Read more

 
Flexicon Liquid Filling

FF30 Aseptic Filling and Capping Machine
The new Flexicon FF30 aseptic filling and capping machine delivers a consistent level of production quality which is impossible to maintain with manual assembly of bottles and caps. Read more


Event Profile
placeholder

Chemspec Europe 2011
15-16 June
Hall 1, PALEXPO
Geneva, Switzerland

Europe’s dedicated fine and speciality chemicals event.
With a focused range of exhibits, easily identified feature areas, free-to-attend conferences and seminars in a relaxed atmosphere with quality ‘face-time’, there’s no more direct or attractive place for taking orders in just two days. Read more

 
 


Survey
Is the pharma industry doing enough to reduce its carbon footprint?
Yes 27%
 
No 73%

This week we would like to know...

Does your company apply continuous processing in any projects in your manufacturing operations?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.